Skip to main content
Erschienen in: Diabetologia 10/2016

Open Access 08.07.2016 | Review

Effects of exercise training on intrahepatic lipid content in humans

verfasst von: Bram Brouwers, Matthijs K. C. Hesselink, Patrick Schrauwen, Vera B. Schrauwen-Hinderling

Erschienen in: Diabetologia | Ausgabe 10/2016

Abstract

Non-alcoholic fatty liver (NAFL) is the most common liver disorder in western society. Various factors may play a role in determining hepatic fat content, such as delivery of lipids to the liver, de novo lipogenesis, hepatic lipid oxidation, secretion of intrahepatic lipids to the circulation or a combination of these. If delivery of lipids to the liver outweighs the sum of hepatic lipid oxidation and secretion, the intrahepatic lipid (IHL) content starts to increase and NAFL may develop. NAFL is closely related to obesity and insulin resistance and a fatty liver increases the vulnerability to type 2 diabetes development. Exercise training is a cornerstone in the treatment and prevention of type 2 diabetes. There is a large body of literature describing the beneficial metabolic consequences of exercise training on skeletal muscle metabolism. Recent studies have started to investigate the effects of exercise training on liver metabolism but data is still limited. Here, first, we briefly discuss the routes by which IHL content is modulated. Second, we review whether and how these contributing routes might be modulated by long-term exercise training. Third, we focus on the effects of acute exercise on IHL metabolism, since exercise also might affect hepatic metabolism in the physically active state. This will give insight into whether the effect of exercise training on IHL could be explained by the accumulated effect of acute bouts of exercise, or whether adaptations might occur only after long-term exercise training. The primary focus of this review will be on observations made in humans. Where human data is missing, data obtained from well-accepted animal models will be used.
Abkürzungen
ACC
Acetyl-CoA carboxylase
ALAT
Alanine aminotransferase
ApoB-100
Apolipoprotein-B100
CS
Citrate synthase
Cyt c
Cytochrome c
DNL
de novo lipogenesis
FAS
Fatty acid synthase
18F-FTHA
14(R,S)-[18F]6-thia-heptadecanoic acid
β-HAD
β-Hydroxyacyl-CoA dehydrogenase
HL
Hepatic lipase
1H-MRS
Proton magnetic resonance spectroscopy
IDL
Intermediate-density lipoprotein
IHL
Intrahepatic lipid
LPL
Lipoprotein lipase
MCD
Methionine- and choline-deficient
NAFL
Non-alcoholic fatty liver
NASH
Non-alcoholic steatohepatitis
PGC-1α
Peroxisome proliferator-activated receptor γ coactivator 1-α
TAG
Triacylglycerol

Intrahepatic lipid accumulation

The prevalence of obesity has reached pandemic proportions [1]. Environmental factors such as consumption of high-energy diets and low levels of physical activity are likely to be underlying factors. Associated with obesity is the excessive storage of lipids in skeletal muscle, heart and liver, known as so-called ‘ectopic’ fat accumulation. In liver, this is diagnosed as non-alcoholic fatty liver (NAFL) if the fat accumulation occurs in the absence of high alcohol consumption. In obese people, the prevalence of NAFL may be as high as 50–70% [2, 3]. In a subset of patients, NAFL may develop into non-alcoholic steatohepatitis (NASH), cirrhosis or liver carcinoma [4]. Although NAFL is thought to be essentially benign and to be fully reversible, NAFL strongly correlates with hepatic and whole-body insulin resistance [2]. Insulin resistance is the earliest hallmark in the development of type 2 diabetes and the prevalence of NAFL in type 2 diabetes is estimated to be as high as 70% [2, 5]. Hepatic lipid accumulation can occur because of changes in the following: (1) NEFA plasma concentrations; (2) lipids originating from a meal; (3) de novo lipogenesis (DNL); (4) hepatic export of VLDLs or (5) hepatic fat oxidation (Fig. 1). These routes are briefly described below.
Conditions in which IHL accumulates
• Increased hepatic NEFA uptake due to higher fasting and/or postprandial plasma NEFA concentrations
• Low partition of fatty acids to skeletal muscle (low chylomicron clearance by muscle and low NEFA uptake)
• Elevated DNL; activated by elevated plasma glucose and insulin concentrations
• Limited capacity to increase hepatic VLDL–TAG secretion and hepatic mitochondrial oxidation
NEFA
Hepatic NEFA uptake is not strictly regulated [6]. Thus, higher plasma NEFA concentrations (predominantly originating from elevated adipose tissue lipolysis) directly relate to a higher hepatic NEFA influx, contributing to higher hepatic triacylglycerol (TAG) content [6, 7]. It has been shown that obese people with high intrahepatic lipid (IHL) content have a twofold higher rate of lipolysis than obese people with normal IHL content [8]. Using isotope tracers, Donnelly et al [9] elegantly showed that during fasting conditions 60% of the hepatic TAG content in patients with NAFL originated from plasma NEFA. Thus, high fasting NEFA concentrations associated with obesity might contribute to elevated IHL content [10]. However, not all studies found an association between fasting NEFA and IHL content [1113], and some suggested that elevated postprandial NEFA concentrations (due to a diminished insulin-inhibitory effect on adipose tissue lipolysis) may be a more important factor contributing to ectopic lipid accumulation [14, 15]. Suppression of plasma NEFA was diminished during insulin infusion [11, 13] and during an OGTT [10] in individuals with elevated IHL content, when compared with obese [10, 13] and lean individuals [11] with normal IHL content. In addition, when comparing patients with NASH with healthy individuals, insulin-stimulated suppression of lipolysis was significantly impaired, while fasting lipolysis was comparable [16]. Thus, impaired insulin-stimulated suppression of lipolysis may be an underlying factor in NAFL.
Lipids originating from a meal
IHL content can directly originate from dietary TAG, transported in chylomicron particles [17]. Release and uptake of TAG-containing chylomicrons occur via lipoprotein lipase (LPL), an enzyme located in the endothelium of adipose tissue and skeletal muscle [17, 18]. The chylomicron remnants then penetrate the fenestrations in the liver for receptor-mediated hepatic uptake [19]. Alternatively, dietary TAG can reach the liver via chylomicron–TAG ‘spillover’ into the serum NEFA pool after incomplete lipolysis via LPL in the adipose tissue and skeletal muscle [17, 19]. Various modulators of LPL, such as liver-produced apolipoproteins and angiopoietin-like proteins, are suggested to influence postprandial fat deposition in the liver [18]. In individuals with NAFL, approximately 15% of the hepatic TAG pool originates from dietary NEFA when a standard diet is consumed [9]. In isoenergetic conditions, the dietary fat concentration seems to be a determinant for the effect on IHL content [2022]. More specifically, consuming an isoenergetic low-fat diet decreased IHL content [21, 22], while consuming an isoenergetic high-fat diet increased IHL content [21, 22]. Contrary to isoenergetic conditions, both low- and high-fat hypoenergetic diets decreased IHL content, often accompanied by a reduction in body weight [23]. In turn, high-carbohydrate and high-fat hyperenergetic diets markedly increased IHL content [23]. Carbohydrate overfeeding with fructose [24] or with glucose [24, 25] both significantly increased IHL content in lean healthy men [24] and overweight/obese men and women [25]. Thus, in energy imbalance, it appears that the composition of the diet may be less important, and that energy intake might be the main determinant for changes in IHL content.
DNL
DNL was initially thought to account for only a small part of the hepatic TAG content in humans. However, insulin is a strong stimulator of DNL [26] and thus in people with hyperinsulinaemia (a common observation in NAFL) DNL may be increased. Indeed, DNL was 5.3- and 3.7-fold higher in hyperinsulinaemic obese individuals in comparison with more insulin-sensitive lean and obese individuals, respectively, after consumption of an isoenergetic high-fat, low-carbohydrate diet for 5 days [27]. In patients with NAFL, DNL contributed up to one-fourth of the hepatic TAG pool measured after an overnight fast [9], and DNL was significantly higher in insulin-resistant individuals with NAFL than in people with low IHL content [28]. Sevastianova et al [25] found that DNL increased in proportion to the increase in IHL content after 3 weeks of carbohydrate overfeeding, directly supporting a role for DNL in hepatic lipid accumulation.
Hepatic VLDL metabolism
Rodents fed a methionine- and choline-deficient (MCD) diet, thereby compromising the assembly of VLDL, are commonly used to investigate NAFL [29]. However, decreased VLDL production is generally not thought to be an underlying factor in the development of NAFL in humans and has only been described in relation to rare apolipoprotein B-100 (ApoB-100) mutations [30]. Contrarily, elevated VLDL–TAG secretion rate upon higher IHL content has been observed repeatedly after an overnight fast [28, 3133] and during the postprandial phase [34, 35]. It is, however, not yet completely clear how IHL content determines the VLDL–TAG secretion rate. While one study suggested a linear relation between IHL content and VLDL–TAG secretion [36], another study found a rise-to-plateau relationship [31]. The latter study described a linear relationship between IHL content and VLDL–TAG secretion in individuals with low IHL content, but not in those with NAFL. Interestingly, the latter study found that, while VLDL–TAG secretion was higher in people with NAFL, VLDL–ApoB-100 production was unchanged [31]. Thus, the liver did not increase VLDL particle production. Therefore, VLDL–TAG secretion might reach its maximum when maximal TAG load in the VLDL particles is reached, and hepatic TAG secretion cannot further compensate for increasing hepatic lipid delivery.
Hepatic mitochondrial metabolism
Lipids are the preferred hepatic energy source during the fasted state [37] and the insulin-resistant fatty liver tends to activate hepatic oxidative metabolism [13, 38]. Hepatic mitochondrial function is elevated in individuals with NAFL, compared with obese controls, and positively correlates with IHL content [8]. In liver biopsies, Koliaki et al [39] found that mitochondrial respiration was higher in obese individuals with and without NAFL compared with lean control individuals, whereas mitochondrial content was comparable. Thus, NAFL develops in the presence of increased hepatic mitochondrial respiration, suggesting that increased lipid oxidation (and VLDL–TAG secretion) cannot fully compensate for the increased lipid delivery. Interestingly, mRNA expression of key components for mitochondrial biogenesis was markedly reduced in individuals with NAFL [39]. This could serve as a precedent for the decreased mitochondrial function observed in individuals with NASH [3942]. Indeed, in NASH patients, activity of all mitochondrial respiratory chain complexes is diminished [42] and hepatic mitochondrial respiration is significantly impaired [39].

Effects of exercise training on IHL content

Liver fat metabolism
Exercise training is a recognised cornerstone in the treatment of obesity and its co-morbidities and recent studies have shown that exercise training might also have beneficial effects on IHL content [4351]. Palmer and Schaffner [52] made one of the earliest observations of a possible link between regular physical activity and NAFL. These workers noted normalisation of alanine aminotransferase (ALAT) plasma levels in overweight patients with NAFL who had reduced their body weight by ≥10% via combined dietary restriction and regular unstructured physical activity. Since then, several studies have used proton magnetic resonance spectroscopy (1H-MRS), the non-invasive gold standard method with which to measure IHL content, to measure directly a reduction in IHL content with a combined weight loss and exercise training programme [53]. Furthermore, in the limited number of liver biopsy studies available, weight loss and exercise training have been found to significantly improve steatosis, lobular inflammation, ballooning injury and NAFLD activity score in patients with NASH [53]. Recently, there has been interest in whether exercise training per se, in the absence of weight loss, can reduce IHL content as well. Until now, however, only a few longitudinal studies that used 1H-MRS have investigated the direct effect of exercise training on IHL content in humans [4351, 54] (Table 1).
Table 1
Main outcomes of studies that measured the effect of exercise training on IHL (measured with 1H-MRS) in humans
Study/participant type
Training protocol
Length of intervention
Intensity of exercise training protocol
Effect on IHL
Effect on other variables
van der Heijden et al (2010) [51]
  Obese Hispanic adolescents
Supervised AET (n = 15)
12 weeks
4×/week, 30 min; 70% of \( \overset{.}{V}{\mathrm{O}}_{2\mathrm{peak}} \)
↓FM, ↓VAT, ↑IS, ↓f-Ins, =f-Glu
  Lean Hispanic adolescents
Supervised AET (n = 14)
12 weeks
4×/week, 30 min; 70% of \( \overset{.}{V}{\mathrm{O}}_{2\mathrm{peak}} \)
No change
=FM, =IS, =f-Ins, =f-Glu
Sullivan et al (2012) [50]
  Obese NAFL patients
Unsupervised AET (n = 12)
16 weeks
5×/week, 30–60 min; 45–55% of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \)
↓ (vs non-exercising control)
=BW, =FM, =f-NEFA
Pugh et al (2014) [49]
  Obese NAFL patients
Supervised AET (n = 13)
16 weeks
3×/week; 30 min at 30% of HRR (weeks 1–4), 30 min at 45% of HRR (weeks 5–8), 45 min at 45% of HRR (weeks 9–12), 45 min at 60% of HRR (weeks 13–16)
↓f-Glu, =IS, =BW, =VAT, =f-Ins
Lee et al (2012) [47]
  Obese adolescent boys
Supervised AET n = 16)
3 months
3×/week; 40 min at 40% of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \) (week 1), 60 min at 60–75% of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \) (weeks 2–12)
↓ (vs non-exercising control)
↓BW, ↓FM, ↓VAT, =IS, =f-Glu, =f-Ins =2 h-Glu, =2 h-Ins
  Obese adolescent boys
Supervised RET (n = 16)
3 months
3×/week, 60 min, 10 exercises, 2× 8–12 repetitions; 60% of 1RM (weeks 1–4), to fatigue (week 5–12)
↓ (vs non-exercising control)
↓BW, ↓FM, ↓VAT, ↑IS, =f-Glu, =f-Ins, =2 h-Glu, =2 h-Ins
Lee et al (2013) [48]
  Obese adolescent girls
Supervised AET (n = 16)
3 months
3×/week; 40 min at 40% of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \) (week 1), 60 min at 60–75% of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \) (weeks 2–12)
↓ (vs non-exercising control)
↓FM, ↓VAT, ↑IS, ↓f-Ins, =f-Glu, =2 h-Glu, =2 h-Ins
  Obese adolescent girls
Supervised RET (n = 16)
3 months
3×/week, 60 min, 10 exercises, 2 × 8–12 repetitions; 60% of 1RM (weeks 1–4), to fatigue (weeks 5–12)
No change (vs non-exercising control)
↓FM, =VAT, =IS, =f-Glu, =f-Ins, =2 h-Glu, =2 h-Ins
Johnson et al (2009) [46]
  Obese men and women
Supervised AET (n = 19)
4 weeks
3×/week, 30–45 min; 50% (week 1), 60% (week 2), 70% (weeks 3 and 4) of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \)
↓ (vs non-exercising control)
↓VAT, ↓f-NEFA, =BW, =f-Glu, =f-Ins
Hallsworth et al (2011) [45]
  Men and women with NAFL
Supervised RET (n = 11)
8 weeks
3×/week, 8 exercises, 45–60 min; 50% (weeks 1–6), 70% (weeks 7 and 8) of 1RM
↑IS, ↓f-Glu, =BW, =FM, =VAT, =f-NEFA, =f-Ins
Finucane et al (2010) [44]
  Older men and women
Supervised AET (n = 50)
12 weeks
3×/week, 60 min; 50% (weeks 1–4), 60% (weeks 5–8), 70% (weeks 9–12) of Wmax
↓ (vs non-exercising control)
↓BW, ↓f-Ins, ↓2 h-Glu, ↓2 h-Ins, =FM, =f-Glu
Bacchi et al (2013) [43]
  Patients with type 2 diabetes and NAFL
Supervised AET (n = 14)
4 months
3×/week, 60 min; 60–65% HRR
↓FM, ↓VAT, ↑IS
  Patients with type 2 diabetes and NAFL
Supervised RET (n = 17)
4 months
3×/week, 9 exercises, 3 × 10 repetitions; 70–80% of 1RM
↓FM, ↓VAT, ↑IS
Shojaee-Moradie et al (2007) [54]
  Overweight healthy men
Supervised AET (n = 10)
6 weeks
3×/week, 20 min; 60–85% of \( \overset{.}{V}{\mathrm{O}}_{2 \max } \)
No change
↑IS, ↓f-NEFA, ↓IS-NEFA, =BW, =FM
1RM, 1 repetition maximum; 2 h-Glu, 2 h glucose (OGTT); 2 h-Ins, 2 h insulin (OGTT); AET, aerobic exercise training programme; BW, body weight; f-Glu, fasting glucose; f-Ins, fasting insulin; FM, fat mass; f-NEFA, fasting NEFA; HRR, heart rate reserve; IS, insulin sensitivity; IS-NEFA, insulin-stimulated NEFA; RET, resistance exercise training programme; VAT, visceral adipose tissue; \( \overset{.}{V}{\mathrm{O}}_{2 \max } \), maximal oxygen uptake; Wmax, maximal performance
In older individuals, 12 weeks of supervised aerobic exercise training for 1 h a day decreased IHL content significantly compared with a non-exercising control group [44]. Consistently, in obese, sedentary adults, 16 weeks of aerobic exercise training five times a week decreased IHL content by 10% in the absence of weight loss [50], and even 4 weeks of aerobic exercise training positively affected IHL content in a comparable group of individuals [46]. One study reported no change in IHL content in overweight healthy men after 6 weeks of aerobic exercise training [54], but exercise was limited to only three sessions of 20 min per week.
In addition, resistance exercise training for 8 weeks was found to reduce IHL content by 13% in obese, sedentary adults [45]. In the study of Bacchi et al [43], it was demonstrated that aerobic training and resistance training decreased IHL content to a similar extent (25–30% decrease from baseline). Van der Heijden et al [51] showed that 12 weeks of aerobic exercise training was also effective in lowering IHL content in younger people, reporting a decrease in IHL content from 8.9% to 5.6% in obese Hispanic adolescents. Interestingly, at least during adolescence, the sex of an individual seems to exert an effect. In the studies performed by Lee et al [47, 48], adolescent boys showed decreased IHL content after both aerobic and resistance exercise [47], while girls only benefited from aerobic exercise training [48].
While the finding that exercise training reduces IHL content is very reproducible, the mechanisms by which exercise training affects IHL content in humans are still unresolved. The simplest view is that the increase in energy expenditure due to physical activity simply induces a negative energy balance, which in turn may result in the mobilisation of hepatic lipids as a substrate to fuel the energy deficit. Most exercise training studies in which IHL content is decreased, however, do not show significant changes in body mass [45, 46, 50] or fat and fat free mass [44, 45, 50]. In fact, only Bacchi et al [43] concluded that there was a significant reduction in BMI and fat mass after exercise training compared with pre-exercise conditions. In Bacchi’s 4 month supervised aerobic or resistance exercise training programme, patients with type 2 diabetes and NAFL performed, three times a week, either 60 min of aerobic exercise training (60–65% of heart rate reserve) or resistance exercise training focusing on nine major muscle groups (70–80% of the 1 repetition maximum). Two months before onset of the training programme participants met with a nutritionist who provided encouragement to follow a healthy diet, and this might have affected the observations. Energy intake was measured by a 3 day food recall just before and at the end of the exercise training intervention. After exercise training, energy intake decreased by 323.8 kJ/day (77.4 kcal/day) in the aerobic training group and 384.5 kJ/day (91.9 kcal/day) in the resistance training group. Therefore, the decrease in energy intake throughout the exercise training programme might have been responsible for reduced BMI and fat mass, rather than the exercise training programme itself.
As outlined above, hepatic lipid accumulation originates due to changes in the delivery of lipids to the liver, changes in hepatic lipid oxidation, changes in the secretion of IHLs to the circulation or a combination of these factors. Since exercise training has the potential to lower IHL content, it may possibly do so by affecting one or more of the pathways involved (see Fig. 1). Below, we review the current knowledge on how exercise training affects the potential pathways involved in hepatic lipid accumulation in humans, supported by rodent data when no human data is available. By doing so, we reveal gaps in the current knowledge and highlight possibilities for future clinical research.
NEFA
Endurance-trained individuals are characterised by low fasting plasma NEFA concentrations [55], suggesting that regular exercise may have an effect on adipose tissue lipid NEFA uptake and lipolysis. In line with this, a 6 month hypoenergetic diet in combination with exercise resulted in decreased in vitro basal adipocyte lipolysis in obese, postmenopausal women [56]. Shojaee-Moradie and colleagues [54] reported a decreased basal glycerol rate of appearance (Ra) and palmitate Ra (indicative of a lower rate of lipolysis) 72 h after a 6 week exercise training programme in sedentary overweight men. However, this was not accompanied by a reduction in IHL content. Other studies did not find exercise training-induced effects on adipose tissue lipolysis. For example, using adipose microdialysis in 17 healthy elderly women, interstitial glycerol levels were found not to be affected after 12 weeks of exercise training [57]. Of note, studies that do report a decrease in adipose tissue lipolysis often observed a parallel decreases in (visceral) adipose tissue mass [54, 56], which can explain part of the observed effect on plasma NEFA concentrations.
Exercise training-induced decreases in IHL content do not necessarily occur in parallel with decreased plasma NEFA concentrations in the fasted state. Several studies report a decrease in IHL content even though fasted plasma NEFA concentrations remained unchanged [45, 50]. Exercise training also promotes whole-body insulin sensitivity and hence might also promote insulin-stimulated suppression of adipose tissue lipolysis [58]. We previously found that 12 weeks of combined aerobic and resistance exercise training improved insulin-mediated suppression of plasma NEFA in both individuals with type 2 diabetes and healthy controls matched for BMI [59]. Similarly, in obese men, 12 weeks of dynamic strength training did improve insulin-stimulated suppression of plasma NEFA [60]. Nevertheless, absolute NEFA levels during insulin infusion were comparable with pre-intervention concentrations, and the effect was mainly due to an increase in fasting plasma NEFA levels after the exercise training protocol. In contrast, no change in insulin-stimulated suppression of plasma NEFA was observed after 12 weeks of aerobic exercise training in people with impaired glucose tolerance [61, 62] and/or impaired fasting glucose [61]. In non-obese sedentary women insulin-stimulated plasma NEFA suppression improved after 9 months of high intensity (80% \( \overset{.}{V}{\mathrm{O}}_{2 \max } \)), but not after moderate-intensity (65% \( \overset{.}{V}{\mathrm{O}}_{2 \max } \)), aerobic exercise training [63].
Next to the potential effect on adipose tissue lipolysis, exercise training may also favour the clearance of plasma NEFA by skeletal muscle. In this respect, it is well established that endurance training improves whole-body fat oxidation [57, 64] and that this is accompanied by higher plasma NEFA uptake in skeletal muscle. With exercise training, this increased capacity for plasma NEFA uptake into the myocyte has been associated with an upregulation of membrane-associated plasma NEFA transport proteins [65]. Using 14(R,S)-[18F]6-thia-heptadecanoic acid (18F-FTHA, a plasma NEFA analogue that is transported across the cellular membrane but is not further metabolised) during a hyperinsulinaemic–euglycaemic clamp, it was found that, compared with healthy sedentary individuals, athletes possessed a higher plasma NEFA uptake in skeletal muscle, while hepatic retention of plasma NEFA was 20% lower [66]. Moreover, using the same plasma NEFA analogue in a monozygotic twin study, hepatic plasma NEFA uptake was 33% lower in the more active twin in comparison with the less active twin during a low-intensity 90 min knee extension exercise [67].
Taken together, exercise training may lower IHL content via effects on plasma NEFA. Whereas the effects on adipose tissue lipolysis are less clear, exercise training does seem to improve plasma NEFA uptake in skeletal muscle. This might lower the plasma NEFA availability for the liver, lowering hepatic plasma NEFA uptake and changing fatty acid partitioning from liver to skeletal muscle.
Lipids originating from a meal
In addition to its effects on plasma NEFA levels, exercise training may also affect postprandial lipid metabolism. It is known that exercise training lowers the serum TAG response to a fatty meal [68] and the prevalence of postprandial hypertriacylglycerolaemia is significantly higher in sedentary people than in trained people [69]. The reduction in postprandial hypertriacylglycerolaemia associated with endurance exercise adaptations is due to a decrease in chylomicron–TAG half-life [70]. The difference in TAG half-life between athletes and sedentary men is most probably due to a direct effect of exercise training on LPL-mediated TAG removal to skeletal muscle [70].
Changes in the activity of LPL may play a major role in the more favourable lipoprotein–lipid profile of physically active individuals. Heparin is known to release LPL from its endothelial binding sites into the circulating blood [7173] and post-heparin plasma LPL activity has been reported to be higher in endurance-trained individuals than in inactive controls [72, 73]. Furthermore, post-heparin LPL activity was reported to be increased after 20 weeks of endurance training in healthy, sedentary individuals [74]. The activity of LPL measured shortly after heparin infusion represents that of LPL derived from skeletal muscle rather than from adipose tissue [71]. This suggests that with exercise training postprandial TAGs are more likely to be taken up by the skeletal muscle.
Hepatic lipase (HL) plays an important role in lipoprotein remodelling [74], hydrolysing TAG and phospholipids from chylomicrons, HDL, intermediate-density lipoprotein (IDL) and LDL [75, 76], so that TAGs are taken up by the liver. It was shown that post-heparin HL activity reduced significantly after 20 weeks of endurance training [74], and this might result in lower postprandial hepatic TAG uptake. Although these indirect measurements suggest postprandial TAG channelling towards skeletal muscle and away from the liver with exercise training, the effect on postprandial hepatic fat storage has not been investigated directly.
DNL
The effect of exercise training on DNL has not been investigated yet in humans. In animal models, however, a limited number of studies have been performed. In OLETF rats, exercise training reduced [77, 78] or prevented [79] hepatic fat storage concomitant with decreases in levels of acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), two key enzymes in hepatic de novo fatty acid synthesis. Thus, at least in rats, there seems to be a link between exercise training-induced effects on IHL content and DNL activity. In all these animal studies, exercise training significantly reduced fasting glucose and fasting insulin levels [7779]. Insulin is known to stimulate DNL from glucose [26], and lowered plasma concentrations of insulin and glucose may therefore blunt DNL. It is well documented that plasma concentrations of insulin and glucose are lower in endurance-trained individuals [80], due to improved whole-body insulin sensitivity [55]. This holds true for the fasted situation but even more so for the metabolic response to a meal. In exercise training studies wherein IHL content was lowered, significant decreases in fasting insulin [44, 48, 51], fasting glucose [45, 49], 2 h (OGTT) glucose [44] and 2 h (OGTT) insulin [44] upon exercise training have been reported. Taken together, while there is no direct human data on DNL activity, the observation of lower glucose and/or insulin levels in humans is in line with the observations made in animal models. Direct measurement of DNL activity before and after exercise training could bring further mechanistic understanding of the IHL content-lowering effect of exercise training in humans.
Hepatic VLDL metabolism
Although VLDL metabolism is generally not thought to be an underlying factor in the development of NAFL in humans, exercise training could still influence IHL content by modifying VLDL metabolism. As yet, no study has investigated the effect of exercise training-induced changes in VLDL metabolism on IHL content in humans, but some studies have investigated how exercise training influences VLDL secretion and clearance. For example, 6 months of supervised exercise training resulted in a significant decrease in VLDL–ApoB-100 secretion rate in obese individuals with type 2 diabetes [81]. The VLDL–ApoB-100 catabolic rate, representing removal of VLDL particles from the vascular compartment by complete hydrolysis to IDL or by direct removal via the hepatic VLDL receptor [81], did not change. Moreover, the VLDL–TAG/ApoB-100 ratio was not altered, suggesting there was no change in TAG content per VLDL particle secreted. Since VLDL–ApoB-100 secretion rate decreased, plasma VLDL–TAG concentrations decreased. These findings were confirmed in a 2 month exercise training experiment with sedentary, non-obese young men [82]. Stable isotope-labelled 1,1,2,3,3-[2H5]glycerol tracer infusion in the post-absorptive phase revealed VLDL–TAG concentrations to be reduced by 28%, due to a 35% reduction in the hepatic VLDL–TAG secretion rate, whereas no differences in VLDL–TAG clearance could be observed. Thus, with exercise training, there seems to be a decrease in hepatic VLDL–TAG secretion. Although this indicates beneficial adaptation in liver metabolism, it cannot explain why exercise training lowers IHL content, since a lower VLDL–TAG secretion would theoretically lead to greater intrahepatic fat storage. Therefore, the reduced VLDL–TAG secretion rate is most likely a consequence of the reduced IHL content upon exercise training.
Hepatic mitochondrial metabolism
The effect of exercise training on hepatic mitochondrial function has not yet been investigated in humans. In rodents, several indices of hepatic mitochondrial content and function were assessed in OLETF rats after a voluntary wheel running [77, 79] or an exercise training programme [78]. In these OLETF rats, exercise training reduced [77, 78] or prevented [79] hepatic fat storage concomitant with a decrease in key intermediates in hepatic fatty acid synthesis. Next to the effect on hepatic steatosis and DNL, these exercised OLETF rats exhibited increased complete palmitate oxidation to CO2 [7779]. Moreover, hepatic citrate synthase (CS) activity [78, 79], β-hydroxyacyl-CoA dehydrogenase (β-HAD) activity [78, 79] and cytochrome c (Cyt c) protein content [77] were significantly upregulated. High CS and β-HAD activity indicates increased aerobic capacity and mitochondrial density, whereas elevated Cyt c protein content suggests enhanced final steps of oxidative phosphorylation. How exercise training might improve hepatic mitochondrial function is still unclear but the mechanism might involve enhanced mitochondrial biogenesis. A study in mice showed that hepatic Cyt c and cytochrome oxidase complex I protein content increased upon exercise training in wild-type mice [83] but the increase was absent in mice deficient in peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) [83]. This suggests that PGC-1α is required for the exercise training-induced adaptations of mitochondrial oxidative proteins in mouse liver. Using phosphorus magnetic resonance spectroscopy to measure hepatic mitochondrial function in relation to changes in IHL content with exercise training should be performed to see whether the observations made in rodents also hold true for humans.
Key effects of exercise training on pathways that influence IHL content
Plasma NEFA
• Increase in plasma NEFA uptake by skeletal muscle
• Some evidence for decrease in fasting and/or postprandial plasma NEFA
Dietary TAG
• Increase in LPL-mediated TAG uptake by skeletal muscle
• Decrease in HL-mediated TAG uptake by liver
DNL
• Decrease in plasma insulin, a key player for the activation of DNL
• In diabetes, exercise can decrease plasma glucose and hence decrease DNL
• Lower ACC and FAS protein content, indicative for decreased de novo lipolysis activity (rodent data)
VLDL metabolism
• Decrease in hepatic VLDL–ApoB-100 and VLDL–TAG secretion, possibly as a consequence of lower hepatic TAG accumulation
Mitochondrial oxidation
• Increase in hepatic CS, β-HAD and Cyt c, indicative for increases in hepatic mitochondrial content and oxidative phosphorylation (rodent data)

Effects of acute exercise on IHL content

Liver fat metabolism
An alternative way to explain the effects of exercise training on IHL content is by considering the accumulating effects of single acute bouts of exercise. However, hepatic fat content is not decreased after acute exercise; in fact, some studies report that acute exercise results in a slightly increased fat content [84, 85].
It has been shown that post-exercise splanchnic NEFA uptake in individuals with type 2 diabetes increases by 25% on average compared with the pre-exercise state [86]. Using stable isotope techniques it was calculated that approximately 50% of whole-body re-esterification immediately after physical exercise (1 h at 60% of \( \overset{.}{V}{\mathrm{O}}_{2\mathrm{peak}} \)) occurs in the splanchnic area [87]. This data indicates that splanchnic (i.e. hepatic) NEFA re-esterification might be an important factor immediately after exercise. So, while long-term exercise training results in lower NEFA levels and decreased IHL content, NEFA are increased after acute exercise and hepatic TAG content tends to increase after acute exercise in the fasted state.
DNL
While it is not yet known how DNL is affected by long-term exercise training in humans, there are some data on the acute effect of exercise. Rabøl and colleagues [88] investigated the effect of a single exercise bout on DNL in insulin-resistant individuals performing 45 min of exercise or rest. After IHL content was determined, study participants were given a high-carbohydrate liquid meal (55 energy% carbohydrates) and deuterium-labelled water to measure DNL rates. They showed that DNL activity was significantly reduced in the exercise condition and this prevented the increase in IHL content that occurred during the resting condition, indicating that exercise positively influenced the rate of DNL after a subsequent meal. In this study, plasma glucose and plasma insulin levels were the same in the exercise and resting conditions but acute exercise induced a threefold increase in postprandial muscle glycogen synthesis. Thus, the single exercise bout redirected plasma glucose towards storage in skeletal muscle instead of liver, most likely via non-insulin-stimulated skeletal muscle glucose uptake by translocation of GLUT-4 [89, 90]. Therefore, eventually, the accumulated lowering effect of single bouts of exercise on DNL, by redirecting plasma glucose towards skeletal muscle, might contribute to the exercise training-induced decreases in IHL content.
Hepatic VLDL metabolism
Exercise training reduces VLDL–TAG secretion and during acute exercise there may be a similar response. Two studies using VLDL–TAG and palmitate tracers measured VLDL secretion directly during, and after 90 min of, aerobic exercise at 50% of the \( \overset{.}{V}{\mathrm{O}}_{2 \max } \) [91, 92]. These studies showed that in both healthy lean individuals and in overweight untrained men hepatic VLDL–TAG secretion and clearance were reduced during exercise and in the early recovery phase. Furthermore, because VLDL–TAG secretion and clearance were both reduced to a similar extent, plasma VLDL–TAG concentrations were not changed. Therefore it can be suggested that, in the early recovery phase, changes in VLDL–TAG secretion and/or clearance do not contribute to decreases in plasma TAG levels.
Plasma TAG levels remain relatively low for 24 h after an acute exercise bout [93], after which they return to baseline values. Although changes in VLDL–TAG metabolism do not contribute to the decrease in plasma TAG in the early recovery phase, it might be that they contribute to the sustained lower plasma TAG the day after a single exercise bout [93]. It has been shown that moderate-intensity exercise bouts lasting at least 2 h reduce plasma TAG concentrations by approximately 30% [9496], whereas shorter bouts of similar exercise have no effect on plasma TAG concentrations [97, 98]. Consistently, it was found that 2 h of evening exercise (60% of the \( \overset{.}{V}{\mathrm{O}}_{2\mathrm{peak}} \)) did increase fasted VLDL-TAG clearance rate by approximately 40% on the following day, without affecting VLDL–TAG secretion in healthy, lean, young men [93]. In women, a comparable exercise protocol decreased VLDL–TAG secretion rate on the following day by approximately 22%, concomitant with increased VLDL–TAG clearance [99]. Thus, performing acute exercise for 2 h in the evening induces changes in VLDL–TAG metabolism on the following day and these changes positively affect TAG concentrations, mainly by causing increased clearance of VLDL–TAG from the plasma and only marginally involving changes in hepatic VLDL–TAG secretion.

Conclusions

NAFL develops due to higher hepatic fat availability and synthesis, which is not fully compensated by increased secretion and oxidation of hepatic TAG. Weight loss plus exercise training is very effective in decreasing IHL content. When body weight is kept constant, exercise training by itself also brings about a distinct, but more modest, decrease in IHL content. Exercise training lowers IHL content most likely via a reduction in hepatic fat availability and synthesis, and an increase in hepatic TAG oxidation. A single bout of exercise seems to increase rather than decrease IHL content and elevated plasma NEFA during exercise and in the post-exercise period might be the main determinant. Clearly, further research needs to be performed to better understand the underlying pathways and systems involved in the beneficial effects of physical activity on hepatic metabolism and crosstalk with whole-body metabolism.

Funding

This work is supported by the Dutch Diabetes Research Foundation (grant no.: 2009.60.003).

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript.

Contribution statement

BB undertook the literature research and drafted and wrote the article. MKCH, PS and VBS-H wrote the article and revised it critically for important intellectual content. All authors approved the version to be submitted.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Ng M, Fleming T, Robinson M et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:766–781CrossRefPubMedPubMedCentral Ng M, Fleming T, Robinson M et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:766–781CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544–1560CrossRefPubMedPubMedCentral Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544–1560CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Johnson NA, Walton DW, Sachinwalla T et al (2008) Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 47:1513–1523CrossRefPubMed Johnson NA, Walton DW, Sachinwalla T et al (2008) Noninvasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disorders. Hepatology 47:1513–1523CrossRefPubMed
4.
Zurück zum Zitat Day CP (2002) Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16:663–678CrossRefPubMed Day CP (2002) Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16:663–678CrossRefPubMed
5.
Zurück zum Zitat Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218CrossRefPubMed Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218CrossRefPubMed
6.
Zurück zum Zitat Bradbury MW (2006) Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290:G194–G198CrossRefPubMed Bradbury MW (2006) Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290:G194–G198CrossRefPubMed
7.
Zurück zum Zitat Tamura S, Shimomura I (2005) Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 115:1139–1142CrossRefPubMedPubMedCentral Tamura S, Shimomura I (2005) Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J Clin Invest 115:1139–1142CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Sunny NE, Parks EJ, Browning JD, Burgess SC (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804–810CrossRefPubMedPubMedCentral Sunny NE, Parks EJ, Browning JD, Burgess SC (2011) Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 14:804–810CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343–1351CrossRefPubMedPubMedCentral Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343–1351CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Holt HB, Wild SH, Wood PJ et al (2006) Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 49:141–148CrossRefPubMed Holt HB, Wild SH, Wood PJ et al (2006) Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia 49:141–148CrossRefPubMed
11.
Zurück zum Zitat Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028CrossRefPubMed Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028CrossRefPubMed
12.
Zurück zum Zitat Tiikkainen M, Tamminen M, Hakkinen AM et al (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859–867CrossRefPubMed Tiikkainen M, Tamminen M, Hakkinen AM et al (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859–867CrossRefPubMed
13.
Zurück zum Zitat Sanyal AJ, Campbell-Sargent C, Mirshahi F et al (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183–1192CrossRefPubMed Sanyal AJ, Campbell-Sargent C, Mirshahi F et al (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183–1192CrossRefPubMed
14.
Zurück zum Zitat Hsieh J, Hayashi AA, Webb J, Adeli K (2008) Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atheroscler Suppl 9:7–13CrossRefPubMed Hsieh J, Hayashi AA, Webb J, Adeli K (2008) Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atheroscler Suppl 9:7–13CrossRefPubMed
15.
Zurück zum Zitat van Hees AM, Jans A, Hul GB, Roche HM, Saris WH, Blaak EE (2011) Skeletal muscle fatty acid handling in insulin resistant men. Obesity 19:1350–1359CrossRefPubMed van Hees AM, Jans A, Hul GB, Roche HM, Saris WH, Blaak EE (2011) Skeletal muscle fatty acid handling in insulin resistant men. Obesity 19:1350–1359CrossRefPubMed
16.
Zurück zum Zitat Armstrong MJ, Hazlehurst JM, Hull D et al (2014) Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis. Diabetes Obes Metab 16:651–660CrossRefPubMedPubMedCentral Armstrong MJ, Hazlehurst JM, Hull D et al (2014) Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis. Diabetes Obes Metab 16:651–660CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jacome-Sosa MM, Parks EJ (2014) Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Curr Opin Lipidol 25:213–220CrossRefPubMed Jacome-Sosa MM, Parks EJ (2014) Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Curr Opin Lipidol 25:213–220CrossRefPubMed
18.
Zurück zum Zitat Kersten S (2014) Physiological regulation of lipoprotein lipase. Biochim Biophys Acta 1841:919–933CrossRefPubMed Kersten S (2014) Physiological regulation of lipoprotein lipase. Biochim Biophys Acta 1841:919–933CrossRefPubMed
19.
Zurück zum Zitat Barrows BR, Timlin MT, Parks EJ (2005) Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens. Diabetes 54:2668–2673CrossRefPubMed Barrows BR, Timlin MT, Parks EJ (2005) Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens. Diabetes 54:2668–2673CrossRefPubMed
20.
Zurück zum Zitat Utzschneider KM, Bayer-Carter JL, Arbuckle MD, Tidwell JM, Richards TL, Craft S (2013) Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr 109:1096–1104CrossRefPubMed Utzschneider KM, Bayer-Carter JL, Arbuckle MD, Tidwell JM, Richards TL, Craft S (2013) Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr 109:1096–1104CrossRefPubMed
21.
Zurück zum Zitat van Herpen NA, Schrauwen-Hinderling VB, Schaart G, Mensink RP, Schrauwen P (2011) Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 96:E691–E695CrossRefPubMed van Herpen NA, Schrauwen-Hinderling VB, Schaart G, Mensink RP, Schrauwen P (2011) Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 96:E691–E695CrossRefPubMed
22.
Zurück zum Zitat Westerbacka J, Lammi K, Hakkinen AM et al (2005) Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804–2809CrossRefPubMed Westerbacka J, Lammi K, Hakkinen AM et al (2005) Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804–2809CrossRefPubMed
24.
Zurück zum Zitat Lecoultre V, Egli L, Carrel G et al (2013) Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity 21:782–785CrossRefPubMed Lecoultre V, Egli L, Carrel G et al (2013) Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity 21:782–785CrossRefPubMed
25.
Zurück zum Zitat Sevastianova K, Santos A, Kotronen A et al (2012) Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr 96:727–734CrossRefPubMed Sevastianova K, Santos A, Kotronen A et al (2012) Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr 96:727–734CrossRefPubMed
26.
Zurück zum Zitat Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N (2014) De novo lipogenesis in health and disease. Metab Clin Exp 63:895–902CrossRefPubMed Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N (2014) De novo lipogenesis in health and disease. Metab Clin Exp 63:895–902CrossRefPubMed
27.
Zurück zum Zitat Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50PubMed Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50PubMed
28.
Zurück zum Zitat Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146:726–735CrossRefPubMed Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146:726–735CrossRefPubMed
29.
30.
Zurück zum Zitat Visser ME, Lammers NM, Nederveen AJ et al (2011) Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia 54:2113–2121CrossRefPubMedPubMedCentral Visser ME, Lammers NM, Nederveen AJ et al (2011) Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia. Diabetologia 54:2113–2121CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S (2008) Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134:424–431CrossRefPubMed Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S (2008) Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134:424–431CrossRefPubMed
32.
Zurück zum Zitat Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430–15435CrossRefPubMedPubMedCentral Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106:15430–15435CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755–765CrossRefPubMed Adiels M, Taskinen MR, Packard C et al (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755–765CrossRefPubMed
34.
Zurück zum Zitat Annuzzi G, De Natale C, Iovine C et al (2004) Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 24:2397–2402CrossRefPubMed Annuzzi G, De Natale C, Iovine C et al (2004) Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 24:2397–2402CrossRefPubMed
35.
Zurück zum Zitat Cassader M, Gambino R, Musso G et al (2001) Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 36:1117–1124CrossRefPubMed Cassader M, Gambino R, Musso G et al (2001) Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 36:1117–1124CrossRefPubMed
36.
Zurück zum Zitat Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S (2010) Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring) 18:1510–1515CrossRef Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S (2010) Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity (Silver Spring) 18:1510–1515CrossRef
37.
Zurück zum Zitat McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49:395–420CrossRefPubMed McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 49:395–420CrossRefPubMed
38.
Zurück zum Zitat Iozzo P, Bucci M, Roivainen A, et al (2010) Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 139:846-856, 856 e841-846 Iozzo P, Bucci M, Roivainen A, et al (2010) Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology 139:846-856, 856 e841-846
39.
Zurück zum Zitat Koliaki C, Szendroedi J, Kaul K et al (2015) Adaptation of hepatic mitochondrial function in humans with non-alcoholic Fatty liver is lost in steatohepatitis. Cell Metab 21:739–746CrossRefPubMed Koliaki C, Szendroedi J, Kaul K et al (2015) Adaptation of hepatic mitochondrial function in humans with non-alcoholic Fatty liver is lost in steatohepatitis. Cell Metab 21:739–746CrossRefPubMed
40.
Zurück zum Zitat Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM (1999) Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282:1659–1664CrossRefPubMed Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM (1999) Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282:1659–1664CrossRefPubMed
41.
Zurück zum Zitat Otsuka H, Harada M, Koga K, Nishitani H (1999) Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS. Magn Reson Imaging 17:283–290CrossRefPubMed Otsuka H, Harada M, Koga K, Nishitani H (1999) Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS. Magn Reson Imaging 17:283–290CrossRefPubMed
42.
Zurück zum Zitat Perez-Carreras M, Del Hoyo P, Martin MA et al (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999–1007CrossRefPubMed Perez-Carreras M, Del Hoyo P, Martin MA et al (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38:999–1007CrossRefPubMed
43.
Zurück zum Zitat Bacchi E, Negri C, Targher G et al (2013) Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with NAFLD (The RAED2 randomized trial). Hepatology 58:1287–1295CrossRefPubMed Bacchi E, Negri C, Targher G et al (2013) Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with NAFLD (The RAED2 randomized trial). Hepatology 58:1287–1295CrossRefPubMed
44.
Zurück zum Zitat Finucane FM, Sharp SJ, Purslow LR et al (2010) The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia 53:624–631CrossRefPubMed Finucane FM, Sharp SJ, Purslow LR et al (2010) The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire Cohort Study: a randomised controlled trial. Diabetologia 53:624–631CrossRefPubMed
45.
Zurück zum Zitat Hallsworth K, Fattakhova G, Hollingsworth KG et al (2011) Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60:1278–1283CrossRefPubMedPubMedCentral Hallsworth K, Fattakhova G, Hollingsworth KG et al (2011) Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60:1278–1283CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Johnson NA, Sachinwalla T, Walton DW et al (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50:1105–1112CrossRefPubMed Johnson NA, Sachinwalla T, Walton DW et al (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50:1105–1112CrossRefPubMed
47.
Zurück zum Zitat Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S (2012) Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 61:2787–2795CrossRefPubMedPubMedCentral Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S (2012) Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes 61:2787–2795CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Lee S, Deldin AR, White D et al (2013) Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am J Physiol Endocrinol Metab 305:E1222–E1229CrossRefPubMedPubMedCentral Lee S, Deldin AR, White D et al (2013) Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial. Am J Physiol Endocrinol Metab 305:E1222–E1229CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Pugh CJA, Sprung VS, Kemp GJ et al (2014) Exercise training reverses endothelial dysfunction in non-alcoholic fatty liver disease. Am J Physiol Heart Circ Physiol 307:1298–1306CrossRef Pugh CJA, Sprung VS, Kemp GJ et al (2014) Exercise training reverses endothelial dysfunction in non-alcoholic fatty liver disease. Am J Physiol Heart Circ Physiol 307:1298–1306CrossRef
50.
Zurück zum Zitat Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S (2012) Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55:1738–1745CrossRefPubMedPubMedCentral Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S (2012) Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 55:1738–1745CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat van der Heijden GJ, Wang ZJ, Chu ZD et al (2010) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) 18:384–390CrossRef van der Heijden GJ, Wang ZJ, Chu ZD et al (2010) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring) 18:384–390CrossRef
52.
Zurück zum Zitat Palmer M, Schaffner F (1990) Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99:1408–1413PubMed Palmer M, Schaffner F (1990) Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99:1408–1413PubMed
53.
Zurück zum Zitat Thoma C, Day CP, Trenell MI (2012) Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 56:255–266CrossRefPubMed Thoma C, Day CP, Trenell MI (2012) Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 56:255–266CrossRefPubMed
54.
Zurück zum Zitat Shojaee-Moradie F, Baynes KC, Pentecost C et al (2007) Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50:404–413CrossRefPubMed Shojaee-Moradie F, Baynes KC, Pentecost C et al (2007) Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism. Diabetologia 50:404–413CrossRefPubMed
55.
Zurück zum Zitat Phielix E, Meex R, Ouwens DM et al (2012) High oxidative capacity due to chronic exercise training attenuates lipid-induced insulin resistance. Diabetes 61:2472–2478CrossRefPubMedPubMedCentral Phielix E, Meex R, Ouwens DM et al (2012) High oxidative capacity due to chronic exercise training attenuates lipid-induced insulin resistance. Diabetes 61:2472–2478CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat You T, Berman DM, Ryan AS, Nicklas BJ (2004) Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 89:1739–1746CrossRefPubMed You T, Berman DM, Ryan AS, Nicklas BJ (2004) Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 89:1739–1746CrossRefPubMed
57.
Zurück zum Zitat Lange KH, Lorentsen J, Isaksson F et al (2001) Endurance training and GH administration in elderly women: effects on abdominal adipose tissue lipolysis. Am J Physiol Endocrinol Metab 280:E886–E897PubMed Lange KH, Lorentsen J, Isaksson F et al (2001) Endurance training and GH administration in elderly women: effects on abdominal adipose tissue lipolysis. Am J Physiol Endocrinol Metab 280:E886–E897PubMed
58.
Zurück zum Zitat Hickner RC, Racette SB, Binder EF, Fisher JS, Kohrt WM (1999) Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise. J Clin Endocrinol Metab 84:3886–3895PubMed Hickner RC, Racette SB, Binder EF, Fisher JS, Kohrt WM (1999) Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise. J Clin Endocrinol Metab 84:3886–3895PubMed
59.
Zurück zum Zitat Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E et al (2010) Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59:572–579CrossRefPubMed Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E et al (2010) Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59:572–579CrossRefPubMed
60.
Zurück zum Zitat Polak J, Moro C, Klimcakova E et al (2005) Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects. Diabetologia 48:2631–2640CrossRefPubMed Polak J, Moro C, Klimcakova E et al (2005) Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects. Diabetologia 48:2631–2640CrossRefPubMed
61.
Zurück zum Zitat Malin SK, Haus JM, Solomon TP, Blaszczak A, Kashyap SR, Kirwan JP (2013) Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab 305:E1292–E1298CrossRefPubMedPubMedCentral Malin SK, Haus JM, Solomon TP, Blaszczak A, Kashyap SR, Kirwan JP (2013) Insulin sensitivity and metabolic flexibility following exercise training among different obese insulin-resistant phenotypes. Am J Physiol Endocrinol Metab 305:E1292–E1298CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Solomon TP, Haus JM, Marchetti CM, Stanley WC, Kirwan JP (2009) Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J Physiol Endocrinol Metab 297:E552–E559CrossRefPubMedPubMedCentral Solomon TP, Haus JM, Marchetti CM, Stanley WC, Kirwan JP (2009) Effects of exercise training and diet on lipid kinetics during free fatty acid-induced insulin resistance in older obese humans with impaired glucose tolerance. Am J Physiol Endocrinol Metab 297:E552–E559CrossRefPubMedPubMedCentral
63.
Zurück zum Zitat DiPietro L, Dziura J, Yeckel CW, Neufer PD (2006) Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol 100:142–149CrossRefPubMed DiPietro L, Dziura J, Yeckel CW, Neufer PD (2006) Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol 100:142–149CrossRefPubMed
64.
Zurück zum Zitat de Glisezinski I, Moro C, Pillard F et al (2003) Aerobic training improves exercise-induced lipolysis in SCAT and lipid utilization in overweight men. Am J Physiol Endocrinol Metab 285:E984–E990CrossRefPubMed de Glisezinski I, Moro C, Pillard F et al (2003) Aerobic training improves exercise-induced lipolysis in SCAT and lipid utilization in overweight men. Am J Physiol Endocrinol Metab 285:E984–E990CrossRefPubMed
65.
Zurück zum Zitat Tunstall RJ, Mehan KA, Wadley GD et al (2002) Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283:E66–E72CrossRefPubMed Tunstall RJ, Mehan KA, Wadley GD et al (2002) Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab 283:E66–E72CrossRefPubMed
66.
Zurück zum Zitat Iozzo P, Takala T, Oikonen V et al (2004) Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia. Diabetes Care 27:2172–2177CrossRefPubMed Iozzo P, Takala T, Oikonen V et al (2004) Effect of training status on regional disposal of circulating free fatty acids in the liver and skeletal muscle during physiological hyperinsulinemia. Diabetes Care 27:2172–2177CrossRefPubMed
67.
Zurück zum Zitat Hannukainen JC, Nuutila P, Borra R et al (2007) Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins. J Physiol 578:347–358CrossRefPubMed Hannukainen JC, Nuutila P, Borra R et al (2007) Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins. J Physiol 578:347–358CrossRefPubMed
68.
Zurück zum Zitat Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr (1983) Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A 80:1449–1453CrossRefPubMedPubMedCentral Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr (1983) Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A 80:1449–1453CrossRefPubMedPubMedCentral
69.
Zurück zum Zitat Ziogas GG, Thomas TR, Harris WS (1997) Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution. Med Sci Sports Exerc 29:986–991CrossRefPubMed Ziogas GG, Thomas TR, Harris WS (1997) Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution. Med Sci Sports Exerc 29:986–991CrossRefPubMed
70.
Zurück zum Zitat Cohen JC, Noakes TD, Benade AJ (1989) Postprandial lipemia and chylomicron clearance in athletes and in sedentary men. Am J Clin Nutr 49:443–447PubMed Cohen JC, Noakes TD, Benade AJ (1989) Postprandial lipemia and chylomicron clearance in athletes and in sedentary men. Am J Clin Nutr 49:443–447PubMed
71.
Zurück zum Zitat Brunzell JD, Chait A, Nikkila EA, Ehnholm C, Huttunen JK, Steiner G (1980) Heterogeneity of primary lipoprotein lipase deficiency. Metabolism 29:624–629CrossRefPubMed Brunzell JD, Chait A, Nikkila EA, Ehnholm C, Huttunen JK, Steiner G (1980) Heterogeneity of primary lipoprotein lipase deficiency. Metabolism 29:624–629CrossRefPubMed
72.
Zurück zum Zitat Kantor MA, Cullinane EM, Sady SP, Herbert PN, Thompson PD (1987) Exercise acutely increases high density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men. Metab Clin Exp 36:188–192CrossRefPubMed Kantor MA, Cullinane EM, Sady SP, Herbert PN, Thompson PD (1987) Exercise acutely increases high density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men. Metab Clin Exp 36:188–192CrossRefPubMed
73.
Zurück zum Zitat Podl TR, Zmuda JM, Yurgalevitch SM et al (1994) Lipoprotein lipase activity and plasma triglyceride clearance are elevated in endurance-trained women. Metabolism 43:808–813CrossRefPubMed Podl TR, Zmuda JM, Yurgalevitch SM et al (1994) Lipoprotein lipase activity and plasma triglyceride clearance are elevated in endurance-trained women. Metabolism 43:808–813CrossRefPubMed
74.
Zurück zum Zitat Ukkola O, Garenc C, Perusse L et al (2001) Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Quebec Family Study. Atherosclerosis 158:199–206CrossRefPubMed Ukkola O, Garenc C, Perusse L et al (2001) Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Quebec Family Study. Atherosclerosis 158:199–206CrossRefPubMed
75.
Zurück zum Zitat Teran-Garcia M, Santoro N, Rankinen T et al (2005) Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study. Diabetes 54:2251–2255CrossRefPubMed Teran-Garcia M, Santoro N, Rankinen T et al (2005) Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study. Diabetes 54:2251–2255CrossRefPubMed
76.
Zurück zum Zitat Jansen H (2004) Hepatic lipase: friend or foe and under what circumstances? Curr Atheroscler Rep 6:343–347CrossRefPubMed Jansen H (2004) Hepatic lipase: friend or foe and under what circumstances? Curr Atheroscler Rep 6:343–347CrossRefPubMed
77.
Zurück zum Zitat Rector RS, Thyfault JP, Morris RT et al (2008) Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 294:G619–G626CrossRefPubMed Rector RS, Thyfault JP, Morris RT et al (2008) Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol 294:G619–G626CrossRefPubMed
78.
Zurück zum Zitat Linden MA, Fletcher JA, Morris EM et al (2014) Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. Am J Physiol Endocrinol Metab 306:E300–E310CrossRefPubMed Linden MA, Fletcher JA, Morris EM et al (2014) Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats. Am J Physiol Endocrinol Metab 306:E300–E310CrossRefPubMed
79.
Zurück zum Zitat Rector RS, Uptergrove GM, Morris EM et al (2011) Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300:G874–G883CrossRefPubMedPubMedCentral Rector RS, Uptergrove GM, Morris EM et al (2011) Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300:G874–G883CrossRefPubMedPubMedCentral
80.
Zurück zum Zitat van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA (2004) Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 287:E558–E565CrossRefPubMed van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA (2004) Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab 287:E558–E565CrossRefPubMed
81.
Zurück zum Zitat Alam S, Stolinski M, Pentecost C et al (2004) The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab 89:688–694CrossRefPubMed Alam S, Stolinski M, Pentecost C et al (2004) The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab 89:688–694CrossRefPubMed
82.
Zurück zum Zitat Tsekouras YE, Magkos F, Kellas Y, Basioukas KN, Kavouras SA, Sidossis LS (2008) High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglyceride secretion rate in men. Am J Physiol Endocrinol Metab 295:E851–E858CrossRefPubMed Tsekouras YE, Magkos F, Kellas Y, Basioukas KN, Kavouras SA, Sidossis LS (2008) High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-triglyceride secretion rate in men. Am J Physiol Endocrinol Metab 295:E851–E858CrossRefPubMed
83.
Zurück zum Zitat Haase TN, Ringholm S, Leick L et al (2011) Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver. Am J Physiol Regul Integr Comp Physiol 301:R1501–R1509CrossRefPubMed Haase TN, Ringholm S, Leick L et al (2011) Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver. Am J Physiol Regul Integr Comp Physiol 301:R1501–R1509CrossRefPubMed
84.
85.
Zurück zum Zitat Shephard RJ, Johnson N (2015) Effects of physical activity upon the liver. Eur J Appl Physiol 115:1–46CrossRefPubMed Shephard RJ, Johnson N (2015) Effects of physical activity upon the liver. Eur J Appl Physiol 115:1–46CrossRefPubMed
86.
Zurück zum Zitat Simonsen L, Henriksen O, Enevoldsen LH, Bulow J (2004) The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects. Diabetologia 47:652–659CrossRefPubMed Simonsen L, Henriksen O, Enevoldsen LH, Bulow J (2004) The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects. Diabetologia 47:652–659CrossRefPubMed
87.
Zurück zum Zitat Van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise. J Physiol 543:1033–1046CrossRefPubMedPubMedCentral Van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise. J Physiol 543:1033–1046CrossRefPubMedPubMedCentral
88.
Zurück zum Zitat Rabøl R, Petersen KF, Dufour S, Flannery C, Shulman GI (2011) Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Proc Natl Acad Sci U S A 108:13705–13709CrossRefPubMedPubMedCentral Rabøl R, Petersen KF, Dufour S, Flannery C, Shulman GI (2011) Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Proc Natl Acad Sci U S A 108:13705–13709CrossRefPubMedPubMedCentral
89.
Zurück zum Zitat Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017CrossRefPubMed Richter EA, Hargreaves M (2013) Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93:993–1017CrossRefPubMed
90.
Zurück zum Zitat Stanford KI, Goodyear LJ (2014) Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ 38:308–314CrossRefPubMedPubMedCentral Stanford KI, Goodyear LJ (2014) Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ 38:308–314CrossRefPubMedPubMedCentral
91.
Zurück zum Zitat Sondergaard E, Rahbek I, Sorensen LP et al (2011) Effects of exercise on VLDL-triglyceride oxidation and turnover. Am J Physiol Endocrinol Metab 300:E939–E944CrossRefPubMedPubMedCentral Sondergaard E, Rahbek I, Sorensen LP et al (2011) Effects of exercise on VLDL-triglyceride oxidation and turnover. Am J Physiol Endocrinol Metab 300:E939–E944CrossRefPubMedPubMedCentral
92.
Zurück zum Zitat Nellemann B, Sondergaard E, Jensen J et al (2014) Kinetics and utilization of lipid sources during acute exercise and acipimox. Am J Physiol Endocrinol Metab 307:E199–E208CrossRefPubMed Nellemann B, Sondergaard E, Jensen J et al (2014) Kinetics and utilization of lipid sources during acute exercise and acipimox. Am J Physiol Endocrinol Metab 307:E199–E208CrossRefPubMed
93.
Zurück zum Zitat Magkos F, Wright DC, Patterson BW, Mohammed BS, Mittendorfer B (2006) Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. Am J Physiol Endocrinol Metab 290:E355–E362CrossRefPubMed Magkos F, Wright DC, Patterson BW, Mohammed BS, Mittendorfer B (2006) Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men. Am J Physiol Endocrinol Metab 290:E355–E362CrossRefPubMed
94.
Zurück zum Zitat Annuzzi G, Jansson E, Kaijser L, Holmquist L, Carlson LA (1987) Increased removal rate of exogenous triglycerides after prolonged exercise in man: time course and effect of exercise duration. Metab Clin Exp 36:438–443CrossRefPubMed Annuzzi G, Jansson E, Kaijser L, Holmquist L, Carlson LA (1987) Increased removal rate of exogenous triglycerides after prolonged exercise in man: time course and effect of exercise duration. Metab Clin Exp 36:438–443CrossRefPubMed
95.
Zurück zum Zitat Cullinane E, Siconolfi S, Saritelli A, Thompson PD (1982) Acute decrease in serum triglycerides with exercise: is there a threshold for an exercise effect? Metabolism 31:844–847CrossRefPubMed Cullinane E, Siconolfi S, Saritelli A, Thompson PD (1982) Acute decrease in serum triglycerides with exercise: is there a threshold for an exercise effect? Metabolism 31:844–847CrossRefPubMed
96.
Zurück zum Zitat Ferguson MA, Alderson NL, Trost SG, Essig DA, Burke JR, Durstine JL (1998) Effects of four different single exercise sessions on lipids, lipoproteins, and lipoprotein lipase. J Appl Physiol 85:1169–1174PubMed Ferguson MA, Alderson NL, Trost SG, Essig DA, Burke JR, Durstine JL (1998) Effects of four different single exercise sessions on lipids, lipoproteins, and lipoprotein lipase. J Appl Physiol 85:1169–1174PubMed
97.
Zurück zum Zitat Altena TS, Michaelson JL, Ball SD, Thomas TR (2004) Single sessions of intermittent and continuous exercise and postprandial lipemia. Med Sci Sports Exerc 36:1364–1371CrossRefPubMed Altena TS, Michaelson JL, Ball SD, Thomas TR (2004) Single sessions of intermittent and continuous exercise and postprandial lipemia. Med Sci Sports Exerc 36:1364–1371CrossRefPubMed
98.
Zurück zum Zitat Cullinane E, Lazarus B, Thompson PD, Saratelli A, Herbert PN (1981) Acute effects of a single exercise session on serum lipids in untrained men. Clin Chim Acta 109:341–344CrossRefPubMed Cullinane E, Lazarus B, Thompson PD, Saratelli A, Herbert PN (1981) Acute effects of a single exercise session on serum lipids in untrained men. Clin Chim Acta 109:341–344CrossRefPubMed
99.
Zurück zum Zitat Bellou E, Siopi A, Galani M et al (2013) Acute effects of exercise and calorie restriction on triglyceride metabolism in women. Med Sci Sports Exerc 45:455–461CrossRefPubMedPubMedCentral Bellou E, Siopi A, Galani M et al (2013) Acute effects of exercise and calorie restriction on triglyceride metabolism in women. Med Sci Sports Exerc 45:455–461CrossRefPubMedPubMedCentral
Metadaten
Titel
Effects of exercise training on intrahepatic lipid content in humans
verfasst von
Bram Brouwers
Matthijs K. C. Hesselink
Patrick Schrauwen
Vera B. Schrauwen-Hinderling
Publikationsdatum
08.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 10/2016
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4037-x

Weitere Artikel der Ausgabe 10/2016

Diabetologia 10/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.